Reviva Pharmaceuticals Hldg Inc (RVPH)

$0.39 +0.04 (10.76%)
Market Cap 4.51M
Revenue (ttm) 0.00
Net Income (ttm) -19.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 742,000
Avg Vol 960,685
Day's Range N/A - N/A
Shares Out 12.81M
Stochastic %K 20%
Beta 0.75
Analysts Strong Sell
Price Target $12.67

Company Profile

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity di...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 501 8881
Fax: 408 904 6270
Address:
10080 N. Wolfe Road, Suite SW3-200, Cupertino, United States
Anomalies
Anomalies Jun. 18 at 10:55 PM
$RVPH
0 · Reply
B2iDigital
B2iDigital Jun. 18 at 9:55 PM
Reviva Pharmaceuticals (OTCQB: $RVPH ) presents its late-stage CNS candidate brilaroxazine at the Life Sciences Virtual Investor Forum on June 24 at 1:30 PM ET. Reviva Pharmaceuticals Holdings, Inc. (OTCQB: RVPH) presents at the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, at 1:30 PM ET on Wednesday, June 24, 2026. The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5389969/reviva-pharmaceuticals-holdings-inc-otcqb-rvph?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC Request a one-on-one meeting: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76 Laxminarayan Bhat, Ph.D. Founder, President, and CEO, presents for Reviva. He founded the company in 2006 and brings over 20 years of drug discovery and development experience, holding more than 100 granted patents as an inventor. Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs. Its pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases, and includes two in-house-discovered new chemical entities, brilaroxazine (RP5063) and RP1208, with composition-of-matter patents granted in the United States, Europe, and several other countries. Learn more at https://revivapharma.com/investors/. Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
1 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 18 at 8:51 PM
$RVPH if you do, you may have to live in a van, down by the river.
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 18 at 8:49 PM
$RVPH
0 · Reply
History101
History101 Jun. 15 at 9:18 PM
$CVKD I still do not own any shares. on 10/24/2025 price was $14.13, and on the day of the post below price was $6.93. Those are declines of 76% and 51% respectively. Just like $RVPH, CVKD will have to raise $$ at a MUCH lower stock price now. Perhaps CVKD should have raised at $14?? or even $6?? wow, just wow. At least I get to take advantage of the poor financial mgmt via a much lower cost basis if and when I do decide to get back in. GLTALs!!
3 · Reply
ying_stock
ying_stock Jun. 12 at 8:01 AM
$GRML when will be like $RVPH
0 · Reply
biovaluable
biovaluable Jun. 12 at 7:56 AM
$RVPH indian scam stock!
1 · Reply
MillennialTrades
MillennialTrades Jun. 12 at 3:05 AM
$RVPH
0 · Reply
sharetp02
sharetp02 Jun. 10 at 10:49 PM
$RVPH - Is this finally taking off?
1 · Reply
bluehorseshoeii
bluehorseshoeii Jun. 10 at 5:25 PM
$RVPH It's at $.726 right now, real time.
1 · Reply
Latest News on RVPH
No data available.
Anomalies
Anomalies Jun. 18 at 10:55 PM
$RVPH
0 · Reply
B2iDigital
B2iDigital Jun. 18 at 9:55 PM
Reviva Pharmaceuticals (OTCQB: $RVPH ) presents its late-stage CNS candidate brilaroxazine at the Life Sciences Virtual Investor Forum on June 24 at 1:30 PM ET. Reviva Pharmaceuticals Holdings, Inc. (OTCQB: RVPH) presents at the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, at 1:30 PM ET on Wednesday, June 24, 2026. The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5389969/reviva-pharmaceuticals-holdings-inc-otcqb-rvph?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC Request a one-on-one meeting: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76 Laxminarayan Bhat, Ph.D. Founder, President, and CEO, presents for Reviva. He founded the company in 2006 and brings over 20 years of drug discovery and development experience, holding more than 100 granted patents as an inventor. Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs. Its pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases, and includes two in-house-discovered new chemical entities, brilaroxazine (RP5063) and RP1208, with composition-of-matter patents granted in the United States, Europe, and several other countries. Learn more at https://revivapharma.com/investors/. Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
1 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 18 at 8:51 PM
$RVPH if you do, you may have to live in a van, down by the river.
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 18 at 8:49 PM
$RVPH
0 · Reply
History101
History101 Jun. 15 at 9:18 PM
$CVKD I still do not own any shares. on 10/24/2025 price was $14.13, and on the day of the post below price was $6.93. Those are declines of 76% and 51% respectively. Just like $RVPH, CVKD will have to raise $$ at a MUCH lower stock price now. Perhaps CVKD should have raised at $14?? or even $6?? wow, just wow. At least I get to take advantage of the poor financial mgmt via a much lower cost basis if and when I do decide to get back in. GLTALs!!
3 · Reply
ying_stock
ying_stock Jun. 12 at 8:01 AM
$GRML when will be like $RVPH
0 · Reply
biovaluable
biovaluable Jun. 12 at 7:56 AM
$RVPH indian scam stock!
1 · Reply
MillennialTrades
MillennialTrades Jun. 12 at 3:05 AM
$RVPH
0 · Reply
sharetp02
sharetp02 Jun. 10 at 10:49 PM
$RVPH - Is this finally taking off?
1 · Reply
bluehorseshoeii
bluehorseshoeii Jun. 10 at 5:25 PM
$RVPH It's at $.726 right now, real time.
1 · Reply
GI197845
GI197845 Jun. 9 at 9:50 PM
$RVPH We are getting rich here folks and helping people at the same time!!!
0 · Reply
GI197845
GI197845 Jun. 9 at 9:49 PM
$RVPH Per Warren Buffet buy when there is blood in the streets! The stock market is a vehicle to take money from impatient people and give it to patient people.
1 · Reply
MillennialTrades
MillennialTrades Jun. 9 at 9:43 PM
$RVPH
0 · Reply
GI197845
GI197845 Jun. 9 at 9:35 PM
$RVPH Back the truck up here folks and git er' done! Load up as much as you can!!! Maybe even a 2nd a 3rd mortgage on the house!
0 · Reply
GI197845
GI197845 Jun. 9 at 9:34 PM
$RVPH Know what you own, stock in a great biotech with a proven track-record of leadership steeped in excellence!
1 · Reply
DistributionEquity
DistributionEquity Jun. 9 at 5:55 PM
$RVPH market cap of 9.3M right now.....for a p3 asset with 20M of cash in the bank and a soon to be extended 15 year patent runway. Pinch me I'm dreaming.
1 · Reply
ERPBlast
ERPBlast Jun. 9 at 4:44 PM
$RVPH this is fcking magic. The market goes up, they are delisted. The market goes down, they go up.
1 · Reply
channelsurfer
channelsurfer Jun. 9 at 4:03 PM
$RVPH @topstockalerts +84% on the 10 day? 😳
0 · Reply
MillennialTrades
MillennialTrades Jun. 9 at 3:37 PM
$RVPH is anyone interested in this? I can’t find any news
1 · Reply
DonkeyPuncherDude
DonkeyPuncherDude Jun. 6 at 12:27 AM
$RVPH WTF 🤬 LAX!!
0 · Reply
channelsurfer
channelsurfer Jun. 5 at 11:34 PM
$RVPH primed for a squeeze 👍 from Google AI: How many shares does retail own? Retail investors own approximately 3.66 million shares of Reviva Pharmaceuticals Holdings, Inc. (RVPH). This figure is calculated using the company's current total of 13.11 million shares outstanding multiplied by the retail ownership allocation of 27.92%. Because the stock trades on the OTCQB venture market with a micro-cap valuation under $10 million, this entire retail-held allocation currently carries a aggregate market value of roughly $2.2 million. The rest of the float remains heavily locked up by hedge funds, institutional blocks (63.18%), and company insiders (8.90%).
0 · Reply
channelsurfer
channelsurfer Jun. 5 at 11:06 PM
$RVPH from Google AI: which institutions or funds have bought rvph at the last offering and up until today? (Thread continues in comments) The $10 million public offering, which closed on March 23, 2026, was executed through the placement agent A.G.P./Alliance Global Partners. Institutional filings submitted up through June 2026 detail the major funds that participated in that capital raise and have maintained or expanded their holdings up until today: Institutional Buyers at the Last Offering & Recent Filings Millennium Management LLC: Led institutional buyers by locking in 793,948 shares. They currently stand as one of the largest institutional positions in the company. Highbridge Capital Management, LLC: Strongly backed the capital raise, building a position of 762,236 shares. Armistice Capital, LLC: Remained a major institutional investor, holding 592,079 shares following the March transactions. (Thread continues in comments)
1 · Reply